Tal Zvi Zaks - Jun 15, 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Director
Signature
/s/ Dov Bergwerk as attorney-in-fact for Tal Zvi Zaks
Stock symbol
TEVA
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4
Date filed
6/20/2023, 07:39 AM
Previous filing
Nov 7, 2022
Next filing
Aug 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +21.1K $0.00 21.1K Jun 15, 2023 Ordinary Shares 21.1K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on June 15, 2023 and vest on June 15, 2024.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.